Drug intelligence / Profile preview

magnesium bisglycinate + levocarnitine tartrate

Development stage
Unknown
Lead developer
Lyf Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Magrico is a combination pharmaceutical product developed and marketed by Lyf Healthcare, primarily indicated for the management of muscle cramps, magnesium deficiency, and neuromuscular health. It consists of magnesium bisglycinate, a highly bioavailable chelated form of magnesium, and L-carnitine L-tartrate. Magnesium acts as a critical cofactor for numerous enzymatic reactions and serves as a physiological calcium antagonist, helping to regulate muscle contraction and nerve conduction. L-carnitine facilitates the transport of long-chain fatty acids into the mitochondria for beta-oxidation and energy production, which is essential for maintaining muscle function and reducing fatigue. The combination is frequently utilized for nocturnal leg cramps, pregnancy-induced cramps, and supportive care in neuropathic conditions.

Brand names
Magrico
Other names
Magnesium Bisglycinate and L-Carnitine L-Tartrate
02

Targets

CaV (Voltage-gated calcium channel protein complex)SLC7A1 (Cationic amino acid transporter 1)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on magnesium bisglycinate + levocarnitine tartrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium bisglycinate + levocarnitine tartrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call